Dilaudid, Injection, 1 mg/1 mL (NDC 76045-009-11)
UNAVAILABLEFresenius Kabi USA, LLC
Reason: Other
Next release September 2026. Check wholesalers for inventory.
Updated Aug 4, 2026
Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 63323-851-15)
UNAVAILABLEFresenius Kabi USA, LLC
Reason: Other
Next release August 2026. Check wholesalers for inventory.
Updated Aug 4, 2026
Dilaudid, Injection, 2 mg/1 mL (NDC 76045-010-11)
UNAVAILABLEFresenius Kabi USA, LLC
Reason: Other
Next release not available at this time. Check wholesalers for inventory.
Updated Aug 4, 2026
Dilaudid, Injection, 1 mg/1 mL (NDC 76045-009-06)
UNAVAILABLEFresenius Kabi USA, LLC
Reason: Other
Next release August 2026. Check wholesalers for inventory.
Updated Aug 4, 2026
Hydromorphone Hydrochloride, Injection, 0.25 mg/ 0.5 mL NexJect™ Single-dose Syringe Luer Lock (no needle) (NDC 0409-1805-01)
UNAVAILABLEHospira, Inc., a Pfizer Company
Reason: Other
Next Delivery: August 2026; Estimated Recovery: September 2026; Shortage per Manufacturer: Manufacturing Delay
Updated Jul 23, 2026
Hydromorphone Hydrochloride, Injection, 1 mg/1 mL (NDC 0409-1283-37)
UNAVAILABLEHospira, Inc., a Pfizer Company
Reason: Other
Next Delivery: October 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay
Updated Jul 23, 2026
Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 0641-6254-01)
UNAVAILABLEHikma Pharmaceuticals USA, Inc.
Reason: Demand increase for the drug
Product temporarily on backorder. Additional lots will be available in the July 2026 timeframe.
Updated Jul 13, 2026
Hydromorphone Hydrochloride, Injection, 0.5 mg/0.5 mL NexJect™ Single-dose Syringe Luer Lock (no needle) (NDC 0409-4264-01)
LIMITEDHospira, Inc., a Pfizer Company
Reason: Other
Limited Supply Available. Next Delivery: September 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay
Updated Jul 23, 2026
Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 0409-3365-10)
LIMITEDHospira, Inc., a Pfizer Company
Reason: Other
Limited Supply Available. Next Delivery: July 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay
Updated Jul 23, 2026
Hydromorphone Hydrochloride, Injection, 4 mg/1 mL (NDC 63323-854-10)
AVAILABLEFresenius Kabi USA, LLC
Check wholesalers for inventory
Updated Aug 4, 2026
Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 0703-0113-03)
AVAILABLETeva Pharmaceuticals USA, Inc.
Updated Aug 4, 2026
Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 63323-851-50)
AVAILABLEFresenius Kabi USA, LLC
Check wholesalers for inventory
Updated Aug 4, 2026
Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 63323-853-25)
AVAILABLEFresenius Kabi USA, LLC
Check wholesalers for inventory
Updated Aug 4, 2026
Hydromorphone Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-852-25)
AVAILABLEFresenius Kabi USA, LLC
Check wholesalers for inventory
Updated Aug 4, 2026
Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 0703-0018-01)
AVAILABLETeva Pharmaceuticals USA, Inc.
Updated Aug 4, 2026
Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 0703-0110-03)
AVAILABLETeva Pharmaceuticals USA, Inc.
Updated Aug 4, 2026
Dilaudid, Injection, .2 mg/1 mL (NDC 76045-121-11)
AVAILABLEFresenius Kabi USA, LLC
Check wholesalers for inventory
Updated Aug 4, 2026
Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 63323-851-10)
AVAILABLEFresenius Kabi USA, LLC
Check wholesalers for inventory
Updated Aug 4, 2026
Hydromorphone Hydrochloride, Injection, 1 mg/1 mL Syringes (NDC 0409-1283-31)
AVAILABLEHospira, Inc., a Pfizer Company
Updated Jul 23, 2026
Hydromorphone Hydrochloride, Injection, 500 mg/50 mL (10 mg/mL) (NDC 0409-2634-50)
AVAILABLEHospira, Inc., a Pfizer Company
Updated Jul 23, 2026
Hydromorphone Hydrochloride, Injection, 50 mg/5 mL (10 mg/mL) (NDC 0409-2634-05)
AVAILABLEHospira, Inc., a Pfizer Company
Updated Jul 23, 2026
Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 0409-2634-01)
AVAILABLEHospira, Inc., a Pfizer Company
Updated Jul 23, 2026
Hydromorphone Hydrochloride, Injection, 4 mg/1 mL Syringes (NDC 0409-1304-31)
AVAILABLEHospira, Inc., a Pfizer Company
Updated Jul 23, 2026
Hydromorphone Hydrochloride, Injection, 2 mg/1 mL Syringes (NDC 0409-1312-30)
AVAILABLEHospira, Inc., a Pfizer Company
Updated Jul 23, 2026
Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 0409-1312-36)
AVAILABLEHospira, Inc., a Pfizer Company
Updated Jul 23, 2026
Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 0641-0121-25)
AVAILABLEHikma Pharmaceuticals USA, Inc.
Additional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released.
Updated Jul 13, 2026
FindRx is a medication availability service — we track which pharmacies have products in stock and route you to them. We are not a pharmacy, we don't sell or dispense medication, and nothing on this page is medical advice. Shortage details come from the FDA Drug Shortages list and manufacturer updates; local stock changes hour to hour, so confirm with the pharmacy at pickup. Questions about whether a medication is right for you belong with your prescriber or pharmacist.